Correction to: miRNA-23b as a biomarker of culture-positive neonatal sepsis
- PDF / 548,481 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 22 Downloads / 174 Views
(2020) 26:129 Fatmi et al. Mol Med https://doi.org/10.1186/s10020-020-00257-0
Open Access
CORRECTION
Correction to: miRNA‑23b as a biomarker of culture‑positive neonatal sepsis Ahlam Fatmi1, Sid Ahmed Rebiahi2, Nafissa Chabni3, Hanane Zerrouki2, Hafsa Azzaoui1, Yamina Elhabiri2, Souheila Benmansour1,4, José Santiago Ibáñez‑Cabellos5,6,7, Mohammed Chems‑Eddine Smahi1,4, Mourad Aribi1, José Luis García‑Giménez5,6,7 and Federico V. Pallardó5,6,7*
Correction to: Molecular Medicine (2020) 26:94 https://doi.org/10.1186/s10020-020-00217 -8
Following publication of the original article (Fanti et al. 2020), the authors identified an error in the author name of Souheila Benmansour. The incorrect author name is: Souheila Benmassour. The correct author name is: Souheila Benmansour. Also, the authors Souheila Benmansour and Mohammed Chems-Eddine Smahi were affiliated incorrectly. The correct affiliation for Souheila Benmansour is: 1 Laboratory of Applied Molecular Biology and Immunology, W0414100 Tlemcen, Algeria. 4 Neonatal Department of Specialized Maternal and Child Hospital of Tlemcen, 13,000 Tlemcen, Algeria. The correct affiliation for Mohammed Chems-Eddine Smahi is: 1 Laboratory of Applied Molecular Biology and Immunology, W0414100 Tlemcen, Algeria. 4 Neonatal Department of Specialized Maternal and Child Hospital of Tlemcen, 13,000 Tlemcen, Algeria. The original article has been corrected.
Author details 1 Laboratory of Applied Molecular Biology and Immunology, W0414100 Tlem‑ cen, Algeria. 2 Laboratory of Microbiology Applied in Food, Biomedical and Environment, Tlemcen, Algeria. 3 Faculty of Medicine, Tlemcen Medical Centre University, 13000 Tlemcen, Algeria. 4 Neonatal Department of Spe‑ cialized Maternal and Child Hospital of Tlemcen, 13000 Tlemcen, Algeria. 5 Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, Spain. 6 Mixed Unit for Rare Diseases INCLIVA‑CIPF, INCLIVA Health Research Institute, Valencia, Spain. 7 Department of Physiol‑ ogy, Faculty of Medicine and Dentistry, University of Valencia, Avenida Blasco Ibañez 15, 46010 Valencia, Spain.
Reference Fatmi, et al. Mol Med. 2020;26:94. https://doi.org/10.1186/s10020-020-00217-8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑ lished maps and institutional affiliations.
The original article can be found online at https://doi.org/10.1186/s1002 0-020-00217-8. *Correspondence: [email protected] 5 Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, Spain Full list of author information is available at the end of the article Mourad Aribi is senior author. © The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Data Loading...
